Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Choosing an index fund involves evaluating costs, tracking accuracy, and liquidity. This quick guide highlights essential factors to help you select wisely.
19,450 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Geopolitical strains in the Gulf collide with political turbulence in Washington, delivering a fresh round of market ...
More than 100 million U.S. adults cannot pay their credit-card balances in full, a sign of growing financial strain a...
Tesla's stock has traded with unusual calm as the company advances robotaxis and semiconductor initiatives. Early pil...
Rivian's R2 carries big expectations at a $60,000 price tag. This piece breaks down what that price means for demand,...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
Billionaire donors are steering college hoops beyond winnings, fueling facilities, NIL deals, and recruiting as the S...
U.S. stocks rebounded from early weakness as oil prices surged on geopolitical tensions. The Nasdaq Composite led the...
A budget deal would fund most Homeland Security programs, including TSA, while leaving ICE operations unfunded. The m...
IBM’s leadership points to a quicker, clearer regulatory path for mergers and acquisitions, citing the Confluent purc...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
Anthropic confirms it is testing a new AI model after a data leak exposed its existence. The company says early acces...